{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:42:43Z","timestamp":1789202563058,"version":"build-2803163510"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Typhoid fever is a serious disease that disproportionately impacts children in low-resource settings in sub-Saharan Africa, South and Southeast Asia, and the Western Pacific. The prevalence of antimicrobial-resistant strains of S. Typhi continue to increase worldwide. Two safe, effective, and cost-effective typhoid conjugate vaccines (TCVs) are World Health Organization-prequalified for the prevention of typhoid fever in children as young as 6 months. Typhoid conjugate vaccines have proven effectiveness in preventing drug-resistant S. Typhi and have been deployed successfully in outbreak response and routine immunization scenarios. Broad and equitable distribution of TCVs is essential to combat the spread and potentially devastating consequences of typhoid fever. It is vital to empower decision-makers in typhoid-endemic countries to introduce TCVs and for leaders to embrace this critical tool to prevent typhoid fever, slow the spread of drug-resistant S. Typhi strains, promote health equity, and save lives.<\/jats:p>","DOI":"10.1093\/ofid\/ofad022","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T17:32:34Z","timestamp":1685727154000},"page":"S6-S12","source":"Crossref","is-referenced-by-count":20,"title":["Using Typhoid Conjugate Vaccines to Prevent Disease, Promote Health Equity, and Counter Drug-Resistant Typhoid Fever"],"prefix":"10.1093","volume":"10","author":[{"given":"Nginache","family":"Nampota-Nkomba","sequence":"first","affiliation":[{"name":"Blantyre Malaria Project, Kamuzu University of Health Sciences , Blantyre , Malawi"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E","family":"Carey","sequence":"additional","affiliation":[{"name":"Cambridge Institute of Therapeutic Immunology and Infectious Disease, Department of Medicine, University of Cambridge , Cambridge , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie P","family":"Jamka","sequence":"additional","affiliation":[{"name":"Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Fecteau","sequence":"additional","affiliation":[{"name":"Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M","family":"Neuzil","sequence":"additional","affiliation":[{"name":"Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"key":"2023060210573319200_ofad022-B1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008048","article-title":"Changes in historical typhoid transmission across 16 U.S. cities, 1889\u20131931: quantifying the impact of investments in water and sewer infrastructures","volume":"14","author":"Phillips","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"Suppl 2","key":"2023060210573319200_ofad022-B2","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1093\/cid\/ciy1117","article-title":"The coalition against typhoid: mobilizing a community for a global fight","volume":"68","author":"Lindsay","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023060210573319200_ofad022-B3","author":"Global Burden of Disease Collaborative Network"},{"issue":"Suppl_2","key":"2023060210573319200_ofad022-B4","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.1093\/cid\/ciy1111","article-title":"Antibiotic resistance and typhoid","volume":"68","author":"Dyson","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023060210573319200_ofad022-B5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007868","article-title":"Molecular mechanism of azithromycin resistance among typhoidal Salmonella strains in Bangladesh identified through passive pediatric surveillance","volume":"13","author":"Hooda","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"2023060210573319200_ofad022-B6","volume-title":"Typhoid vaccines: WHO position paper\u2014March 2018","author":"World Health Organization","year":"2018"},{"key":"2023060210573319200_ofad022-B7","author":"World Health Organization","year":"2022","journal-title":"Weekly epidemiological record"},{"key":"2023060210573319200_ofad022-B8","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa2035916","article-title":"Safety and efficacy of a typhoid conjugate vaccine in Malawian children","volume":"385","author":"Patel","year":"2021","journal-title":"N Engl J Med"},{"key":"2023060210573319200_ofad022-B9","doi-asserted-by":"crossref","first-page":"e1561","DOI":"10.1016\/S2214-109X(21)00346-6","article-title":"Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial","volume":"9","author":"Shakya","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2023060210573319200_ofad022-B10","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0140-6736(21)01124-7","article-title":"Protection by vaccination of children against typhoid fever with a vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial","volume":"398","author":"Qadri","year":"2021","journal-title":"Lancet"},{"key":"2023060210573319200_ofad022-B11","doi-asserted-by":"crossref","first-page":"e927","DOI":"10.1093\/cid\/ciab059","article-title":"Evaluation of vaccine safety after the first public sector introduction of typhoid conjugate vaccine-Navi Mumbai, India, 2018","volume":"73","author":"Longley","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023060210573319200_ofad022-B12","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1016\/S2214-109X(22)00466-1","article-title":"Typhoid conjugate vaccine effectiveness in Malawi: evaluation of a test-negative design using randomised, controlled clinical trial data","volume":"11","author":"Liang","year":"2023","journal-title":"Lancet Glob Health"},{"key":"2023060210573319200_ofad022-B13","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ijid.2021.05.061","article-title":"Safety and immunogenicity of vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: a randomized controlled phase 2 trial","volume":"108","author":"Sirima","year":"2021","journal-title":"Int J Infect Dis"},{"key":"2023060210573319200_ofad022-B14","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ijid.2020.10.103","article-title":"Safety and immunogenicity of co-administration of meningococcal type A and measles-rubella vaccines with typhoid conjugate vaccine in children aged 15\u201323 months in Burkina Faso","volume":"102","author":"Sirima","year":"2021","journal-title":"Int J Infect Dis"},{"key":"2023060210573319200_ofad022-B15","doi-asserted-by":"crossref","first-page":"e1326","DOI":"10.1016\/S2214-109X(22)00275-3","article-title":"Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi: a nested substudy of a double-blind, randomised controlled trial","volume":"10","author":"Nampota-Nkomba","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2023060210573319200_ofad022-B16","author":"SAGE Working Group on Typhoid Vaccines and WHO Secretariat","year":"2017"},{"key":"2023060210573319200_ofad022-B17","doi-asserted-by":"crossref","first-page":"e1154","DOI":"10.1016\/S2214-109X(21)00255-2","article-title":"Effectiveness of typhoid conjugate vaccine against culture-confirmed Salmonella enterica serotype Typhi in an extensively drug-resistant outbreak setting of hyderabad, Pakistan: a cohort study","volume":"9","author":"Yousafzai","year":"2021","journal-title":"Lancet Glob Health"},{"key":"2023060210573319200_ofad022-B18","doi-asserted-by":"crossref","first-page":"e655","DOI":"10.1016\/S2666-5247(21)00311-6","article-title":"Zimbabwe Tackles typhoid and cholera through vaccination","volume":"2","author":"Bagcchi","year":"2021","journal-title":"Lancet Microbe"},{"key":"2023060210573319200_ofad022-B19","doi-asserted-by":"crossref","first-page":"4199","DOI":"10.1016\/j.vaccine.2022.04.093","article-title":"Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak among children and young adults: a matched case control study","volume":"40","author":"Lightowler","year":"2022","journal-title":"Vaccine"},{"key":"2023060210573319200_ofad022-B20","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S1473-3099(19)30425-6","article-title":"Typhoid vi-conjugate vaccine for outbreak control in Zimbabwe","volume":"19","author":"Olaru","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2023060210573319200_ofad022-B21","doi-asserted-by":"crossref","first-page":"6682","DOI":"10.1016\/j.vaccine.2021.07.073","article-title":"Persisting antibody responses to vi polysaccharide-tetanus toxoid conjugate (typbar TCV\u00ae) vaccine up to 7\u202fyears following primary vaccination of children &lt;\u202f2 years of age with, or without, a booster vaccination","volume":"39","author":"Vadrevu","year":"2021","journal-title":"Vaccine"},{"issue":"Suppl_5","key":"2023060210573319200_ofad022-B22","doi-asserted-by":"crossref","first-page":"S375","DOI":"10.1093\/cid\/ciz551","article-title":"Typhoid-from past to future","volume":"69","author":"Kirchhelle","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023060210573319200_ofad022-B23","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","journal-title":"Lancet"},{"key":"2023060210573319200_ofad022-B24","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1017\/S0022172400024360","article-title":"The problem and implications of chloramphenicol resistance in the typhoid bacillus","volume":"74","author":"Anderson","year":"1975","journal-title":"J Hyg (Lond)"},{"key":"2023060210573319200_ofad022-B25","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1128\/AAC.00294-07","article-title":"Antimicrobial drug resistance of Salmonella enterica serovar typhi in Asia and molecular mechanism of reduced susceptibility to the fluoroquinolones","volume":"51","author":"Chau","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2023060210573319200_ofad022-B26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.00105-18","article-title":"Emergence of an extensively drug-resistant Salmonella enterica serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins","volume":"9","author":"Klemm","year":"2018","journal-title":"MBio"},{"key":"2023060210573319200_ofad022-B27","doi-asserted-by":"crossref","first-page":"e00215","DOI":"10.1128\/mSphere.00215-20","article-title":"A race against time: reduced azithromycin susceptibility in Salmonella enterica serovar Typhi in Pakistan","volume":"5","author":"Iqbal","year":"2020","journal-title":"mSphere"},{"key":"2023060210573319200_ofad022-B28","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlaa109","article-title":"The emergence of azithromycin-resistant Salmonella Typhi in Nepal","volume":"2","author":"Duy","year":"2020","journal-title":"JAC Antimicrob Resist"},{"key":"2023060210573319200_ofad022-B29","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1093\/cid\/ciaa1773","article-title":"Spontaneous emergence of azithromycin resistance in independent lineages of Salmonella Typhi in Northern India","volume":"72","author":"Carey","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023060210573319200_ofad022-B30","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ng.3281","article-title":"Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events","volume":"47","author":"Wong","year":"2015","journal-title":"Nat Genet"},{"key":"2023060210573319200_ofad022-B31","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.4269\/ajtmh.20-0258","article-title":"A systematic review on antimicrobial resistance among Salmonella Typhi worldwide","volume":"103","author":"Marchello","year":"2020","journal-title":"Am J Trop Med Hyg"},{"key":"2023060210573319200_ofad022-B32","doi-asserted-by":"crossref","first-page":"e893","DOI":"10.1016\/S2542-5196(21)00280-1","article-title":"Global antibiotic consumption and usage in humans, 2000\u201318: a spatial modelling study","volume":"5","author":"Browne","year":"2021","journal-title":"Lancet Planet Health"},{"key":"2023060210573319200_ofad022-B33","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1016\/S1473-3099(18)30350-5","article-title":"Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance","volume":"19","author":"Andrews","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"2023060210573319200_ofad022-B34","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S1473-3099(18)30804-1","article-title":"Cost-effectiveness of routine and campaign use of typhoid vi-conjugate vaccine in Gavi-eligible countries: a modelling study","volume":"19","author":"Bilcke","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"Suppl_2","key":"2023060210573319200_ofad022-B35","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/cid\/ciy1108","article-title":"Predicting the impact of typhoid conjugate vaccines on antimicrobial resistance","volume":"68","author":"Kaufhold","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023060210573319200_ofad022-B36","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1473-3099(21)00627-7","article-title":"Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study","volume":"22","author":"Birger","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2023060210573319200_ofad022-B37","doi-asserted-by":"crossref","first-page":"e1011","DOI":"10.1093\/cid\/ciab062","article-title":"Leveraging vaccines to reduce antibiotic use and prevent antimicrobial resistance: a World Health Organization action framework","volume":"73","author":"Vekemans","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023060210573319200_ofad022-B38","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.cmi.2019.06.030","article-title":"Impact of vaccination on antibiotic usage: a systematic review and meta-analysis","volume":"25","author":"Buckley","year":"2019","journal-title":"Clin Microbiol Infect"},{"key":"2023060210573319200_ofad022-B39","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-058740","article-title":"Antibiotic use attributable to specific aetiologies of diarrhoea in children under 2 years of age in low-resource settings: a secondary analysis of the MAL-ED birth cohort","volume":"12","author":"Brennhofer","year":"2022","journal-title":"BMJ Open"},{"key":"2023060210573319200_ofad022-B40","author":"World Health Organization"},{"key":"2023060210573319200_ofad022-B41","author":"World Health Organization"},{"key":"2023060210573319200_ofad022-B42","author":"World Health Organization"},{"key":"2023060210573319200_ofad022-B43","author":"Mukhopadhyay"},{"issue":"Suppl_2","key":"2023060210573319200_ofad022-B44","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.1093\/cid\/ciaa314","article-title":"Tenacious endemic typhoid fever in Samoa","volume":"71","author":"Sikorski","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"Suppl 1","key":"2023060210573319200_ofad022-B45","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1093\/cid\/ciy957","article-title":"Integrating typhoid fever within the sustainable development goals: pragmatism or utopia?","volume":"68","author":"Bhutta","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2023060210573319200_ofad022-B46","doi-asserted-by":"crossref","first-page":"e578","DOI":"10.1016\/S2666-5247(22)00114-8","article-title":"Estimating typhoid incidence from community-based serosurveys: a multicohort study","volume":"3","author":"Aiemjoy","year":"2022","journal-title":"Lancet Microbe"},{"issue":"9","key":"2023060210573319200_ofad022-B47","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1007\/s00268-020-05567-2","article-title":"Morbidity and mortality of typhoid intestinal perforation among children in sub-Saharan Africa 1995\u20132019: a scoping review","volume":"44","author":"Birkhold","year":"2020","journal-title":"World J Surg"},{"issue":"Suppl 2","key":"2023060210573319200_ofad022-B48","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1093\/cid\/ciaa405","article-title":"Intestinal perforations associated with a high mortality and frequent complications during an epidemic of multidrug-resistant typhoid fever in Blantyre, Malawi","volume":"71","author":"Olgemoeller","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2023060210573319200_ofad022-B49","author":"Neuzil"},{"key":"2023060210573319200_ofad022-B50","author":"World Health Organization"},{"key":"2023060210573319200_ofad022-B51","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0889-8561(03)00097-3","article-title":"Does antigenic overload exist? The role of multiple immunizations in infants","volume":"23","author":"Gregson","year":"2003","journal-title":"Immunol Allergy Clin North Am"},{"key":"2023060210573319200_ofad022-B52","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1542\/peds.81.2.237","article-title":"Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines","volume":"81","author":"Deforest","year":"1988","journal-title":"Pediatrics"},{"key":"2023060210573319200_ofad022-B53","first-page":"288","article-title":"Simultaneous administration of live attenuated measles vaccine with DTP vaccine","volume":"62","author":"McBean","year":"1978","journal-title":"Pediatrics"},{"key":"2023060210573319200_ofad022-B54","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4269\/ajtmh.1974.23.685","article-title":"Multiple antigen vaccine strategies in developing countries","volume":"23","author":"Foege","year":"1974","journal-title":"Am J Trop Med Hyg"},{"key":"2023060210573319200_ofad022-B55","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijid.2022.03.004","article-title":"The show is not over\u2014wild-type polio in Malawi is a wake-up call and an opportunity for elimination efforts","volume":"119","author":"McCarthy","year":"2022","journal-title":"Int J Infect Dis"},{"key":"2023060210573319200_ofad022-B56","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S1473-3099(21)00340-6","article-title":"Measles immunisation gaps in Africa","volume":"21","author":"Bagcchi","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"2023060210573319200_ofad022-B57","author":"Oberman"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/Supplement_1\/S6\/50508720\/ofad022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/10\/Supplement_1\/S6\/50508720\/ofad022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T17:33:05Z","timestamp":1685727185000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/10\/Supplement_1\/S6\/7188909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":57,"journal-issue":{"issue":"Supplement_1","published-print":{"date-parts":[[2023,6,2]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofad022","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,5]]},"published":{"date-parts":[[2023,5]]}}}